Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVER Pilot: Rosuvastatin for Venous Event Reduction in VTE Patients
NCT02679664Phase 2Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Nov 2016
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of rosuvastatin in venous thromboembolism (VTE), post-thrombotic syndrome (PTS), sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
venous thromboembolism (VTE)post-thrombotic syndrome (PTS)
Beyond the preview
Go deeper on NCT02679664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02679664.